Filtered By:
Cancer: Ovarian Cancer

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 484 results found since Jan 2013.

A fifth operation and permanent menopause
Number of days since surgery: 13Pain level: manageableMood: relieved!It's been quite a while since I last wrote but, as usual, plenty has happened! I've been put into chemical menopause, taken out of chemical menopause, put back into chemical menopause again and now I'm recovering from yet more major surgery. And I'm finally in permanent menopause.Last April, as an attempt to control the high level of pain I was having, my oncology surgeon put me on a course of Prostap injections (you can read more about this in my previous blog post). His thinking was that by temporarily shutting down my remaining ovary he could see wheth...
Source: Diary of a Cancer Patient - February 24, 2015 Category: Cancer & Oncology Source Type: blogs

Vaccinating Against Iron-Deficiency Anemia: A New Technology For Maternal And Child Health
When we think of killer diseases of global health importance, iron-deficiency anemia (IDA) is not something that immediately comes to mind. Yet the December 2014 publication of leading causes of death by the Global Burden of Disease Study 2013 reveals that IDA kills an estimated 183,400 people annually. To put this number in perspective, in the year 2013, IDA killed more people worldwide than ovarian cancer. In terms of years of life lost, IDA ranked higher than cervical cancer. The fact that we compared IDA to two other well-known threats to the health of women is no accident. Because women of child-bearing age have low u...
Source: Health Affairs Blog - February 19, 2015 Category: Health Management Authors: Peter Hotez and Remko van Leeuwen Tags: All Categories Global Health Health Care Delivery Nonmedical Determinants Pharma Prevention Public Health Source Type: blogs

What is a serious diagnosis?
The serious diagnosis is a polite middle-aged woman with a hopeful smile sitting on the side of the bed, with her husband in the chair across from her, as you carefully tell them what it means to have ovarian cancer. The serious diagnosis is the teenager who just found out he has lupus nephritis — without any other signs or symptoms of lupus — and that he might be on hemodialysis soon if high-dose steroids and chemotherapy don’t work.  He has a three-month-old infant. Continue reading ... Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how.
Source: Kevin, M.D. - Medical Weblog - February 5, 2015 Category: Journals (General) Authors: Tags: Physician Primary care Source Type: blogs

Removing the Fallopian Tubes to Prevent Ovarian Cancer – Something to Consider
New information strongly suggests that most ovarian cancers originate, not in the ovary, but in the fallopian tube. If this is so, then removal of the fallopian tubes may actually prevent ovarian cancer. The evidence is powerful enough that the American Congress of Obstetricians & Gynecologists is now recommending that fallopian tube removal be considered in women planning to undergo surgical sterilization or hysterectomy. The Fallopian Tube Origin of Ovarian Cancer We used to think that ovarian cancer originated in the peritoneal lining that covers the ovaries and abdominal organs. But the fallopian tube origin of ova...
Source: The Blog That Ate Manhattan - January 23, 2015 Category: Primary Care Authors: Margaret Polaneczky, MD Tags: Best of TBTAM Family Planning Ovarian Cancer Essure Fallopian tube oophorectomy prophylactic salpingectomy Sterilization Tie my tuibes tubal ligation Tubes Source Type: blogs

Some history of hype regarding the human genome project and genomics
Just taking some notes here - relates to a discussion going on online.  Would love pointers to other references relating to hype and the human genome project (including references that think it was not overhyped).  I note - see some of my previous posts about this issue including: Human genome project oversold? sure but lets not undersell basic science and various Overselling Genomics awards. Here are some things I have found:White House press conference on announcing completetion of the human genomeGenome science will have a real impact on all our lives -- and even more, on the lives of our children. I...
Source: The Tree of Life - December 6, 2014 Category: Medical Scientists Authors: Jonathan Eisen Source Type: blogs

Top stories in health and medicine, November 17, 2014
From MedPage Today: Ebola: Signs of Progress, CDC says. The response to the Ebola outbreak in Liberia is showing encouraging signs of progress, with downward trends in new cases especially in two regions of the country that had been hot spots. Millions Of Medicaid Kids Missing Regular Checkups. Millions of low-income children are failing to get the free preventive exams and screenings guaranteed by Medicaid, and the Obama administration is not doing enough to fix the problem. Some Pregnancy Risks for Young Kidney Donors. Young women who donate a kidney may be at higher risk of gestational hypertension and preeclampsia wh...
Source: Kevin, M.D. - Medical Weblog - November 17, 2014 Category: Journals (General) Authors: Tags: News Cancer Infectious disease Nephrology Source Type: blogs

BRCA 1 & 2 Gene Testing: What Does A Positive Test Mean And Should You Get Tested?
The BRCA 1 and 2 gene mutations, and a handful of other (rarer) gene mutations, account for about 10% of all breast cancer cases. The abnormal genes affect about 1 in 400 people and can be inherited from either or both parents. BRCA gene mutations increase the lifetime risk of breast cancer in women to between 50 and 87% (depending on the study). The lifetime risk of breast cancer in the general population is about 12%. Due to the publicity BRCA has received in the media lately, most people think it only affects women. That's not true. Men can be affected too. Men carrying an abnormal BRCA gene have a 5-10% risk of getti...
Source: Breast Cancer Reconstruction Blog - October 27, 2014 Category: Cancer & Oncology Tags: BRCA BRCA1 BRCA2 breast cancer colon fallopian tube family history of breast cancer gene mutation genetic counseling genetic testing melanoma ovarian pancreatic peritoneal Source Type: blogs

The Saatchi bill won’t find a cure for cancer, but it will encourage charlatans
Jump to follow-up Maurice Nathan Saatchi, Baron Saatchi is an advertising man who, with his brother, Charles Saatchi ("‘why tell the truth when a good lie will do?), became very rich by advertising cigarettes and the Conservative party. After his second wife died of cancer he introduced a private members bill in the House of Lords in 2012. The Medical Innovation Bill came back to the Lords for its second reading on 24 October 2014. The debate was deeply depressing: very pompous and mostly totally uninformed. You would never have guessed that the vast majority of those who understand the problem are a...
Source: DC's goodscience - October 24, 2014 Category: Science Authors: David Colquhoun Tags: business CAM cancer Cancer act Saatchi Bill alternative medicine antiscience badscience Source Type: blogs

Towards the Indefinite Postponement of Menopause
The future elimination of menopause through medical advances to treat aging has been in the news of late. Menopause is an undesirable thing that happens during aging, and the ultimate objective of rejuvenation research projects is to indefinitely postpone all of the undesirable things that happen during aging. Degenerative aging is a combination of primary damage, spiraling secondary forms of damage, and the evolved reactions of still-functioning systems to that damage. The best way forward to deal with all of this is that of the SENS research programs, among other lines of research: repair the damage. Don't try to compens...
Source: Fight Aging! - October 10, 2014 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs

Free the Data Announces New Partnership with Rep.Wasserman Schultz
WASHINGTON, DC (October 8, 2014)—Free the Data, a national coalition of organizations dedicated to freeing genetic information, announced that U.S. Rep. Debbie Wasserman Schultz (FL-23) was named its Honorary Chair. “The time for hoarding data as a commodity is over,” said Sharon Terry, President and CEO of Genetic Alliance, the nonprofit health advocacy organization that coordinates Free the Data. “The Coalition is thrilled to have a powerful partnership with Congresswoman Wasserman Schultz. In Breast Cancer Awareness Month, we are confident that the Congresswoman adds strength and momentum to the Free the Data mo...
Source: Disruptive Women in Health Care - October 9, 2014 Category: Consumer Health News Authors: dw at disruptivewomen.net Tags: Access Advocacy Cancer Genetics Policy Source Type: blogs

A Way to Kill Chemo-Resistant Ovarian Cancer Cells: Cut Down Their Protector
A recent study provides new insight into why ovarian cancer is often resistant to chemotherapy, as well as a potential way to improve its diagnosis and treatment. Ovarian cancer is the most lethal gynecological cancer, claiming the lives of more than 60% of women who are diagnosed with the disease. A study involving Ottawa and […]
Source: Libby's H*O*P*E* - September 25, 2014 Category: Cancer & Oncology Authors: Paul Cacciatore Tags: Discoveries Medical Study Results Preclinical Testing chemoresistance Dr. Ben Tsang Dr. Dar-Bin Shieh gelsolin protein Ottawa Hospital Research Instit. ovarian cancer Source Type: blogs